Medical treatment of Alzheimer's disease: past, present, and future.
Memorial Hospital Alzheimer's Disease and Memory Disorders Center, Pawtucket, RI, USA. Brian_Ott@mhri.org
Brian R
BR
Ott
D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000175:diagnosis / Q000188:drug therapy*; D002219:Carbamates / Q000008:administration & dosage; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D000077265:Donepezil; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005544:Forecasting; D005702:Galantamine / Q000008:administration & dosage; D006801:Humans; D007189:Indans / Q000008:administration & dosage; D008297:Male; D048448:Phenylcarbamates; D010880:Piperidines / Q000008:administration & dosage; D011379:Prognosis; D000068836:Rivastigmine; D012720:Severity of Illness Index; D013619:Tacrine / Q000008:administration & dosage; D016896:Treatment Outcome
D002219:Carbamates; D002800:Cholinesterase Inhibitors; D007189:Indans; D048448:Phenylcarbamates; D010880:Piperidines; D005702:Galantamine; D013619:Tacrine; D000077265:Donepezil; D000068836:Rivastigmine